CAFs-released exosomal CREB1 promotes cell progression and immune evasion in thyroid cancer via the positive regulation of CCL20
Background Exosomes derived from cancer-associated fibroblasts (CAFs) can affect tumor microenvironment (TME) of thyroid cancer (TC). The cAMP response element binding protein 1 (CREB1) acts as a transcription factor to participate in cancer development. Currently, we aimed to explore the molecular...
Saved in:
Main Authors: | Chen Zheng, Hu Hei, Yifei Zhai, Wenbo Gong, Runfang Zhang, Songtao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Autoimmunity |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/08916934.2025.2458324 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis
by: Xue Gu, et al.
Published: (2024-12-01) -
COMMON SELF-EVALUATION FRAMEWORK (CAF) FOR THE EDUCATION SYSTEM
by: Alexandra IANCU
Published: (2024-05-01) -
Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
by: WenDong Chen, et al.
Published: (2025-01-01) -
Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01) -
PABPN1 functions as a downstream gene of CREB to inhibit the proliferation of preadipocytes
by: Xiao-Han Zhang, et al.
Published: (2025-01-01)